RT Journal Article
SR Electronic
T1 Circulating PACAP levels are associated with altered imaging measures of entorhinal cortex neurite density in posttraumatic stress disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.31.23294894
DO 10.1101/2023.08.31.23294894
A1 Steven J Granger
A1 Victor May
A1 Sayamwong E Hammack
A1 Eylül Akman
A1 Sydney A. Jobson
A1 Elizabeth A Olson
A1 Cameron D Pernia
A1 Nikos P Daskalakis
A1 Caitlin Ravichandran
A1 William A Carlezon, Jr.
A1 Kerry J Ressler
A1 Scott L Rauch
A1 Isabelle M Rosso
YR 2023
UL http://medrxiv.org/content/early/2023/08/31/2023.08.31.23294894.abstract
AB Background Pituitary adenylate cyclase-activating polypeptide (PACAP) regulates plasticity in brain systems underlying arousal and memory and is associated with posttraumatic stress disorder (PTSD). Research in animal models suggests that PACAP modulates entorhinal cortex (EC) input to the hippocampus, contributing to impaired contextual fear conditioning. In PTSD, PACAP is associated with higher activity of the amygdala to threat stimuli and lower functional connectivity of the amygdala and hippocampus. However, PACAP-affiliated structural alterations of these regions have not been reported. Here, we examined whether peripheral PACAP levels were associated with neuronal morphology of the amygdala and hippocampus (primary analysis), and EC (secondary analysis) using Neurite Orientation Dispersion and Density Imaging.Methods Sixty-four (44 female) adults (19 to 54 years old) with DSM-5 Criterion A trauma exposure completed the Clinician-Administered PTSD Scale (CAPS-5), a blood draw, and magnetic resonance imaging. PACAP38 radioimmunoassay was performed and T1-weighted and multi-shell diffusion- weighted images were acquired. Neurite Density Index (NDI) and Orientation Dispersion Index (ODI) were quantified in the amygdala, hippocampus, and EC. CAPS-5 total score and anxious arousal score were used to test for clinical associations with brain structure.Results Higher PACAP levels in blood were associated with greater EC NDI (β=0.31, q=0.034) and lower EC ODI (β=-0.30, q=0.042) and not hippocampal or amygdala measures. Neither EC NDI nor ODI was associated with clinical measures.Conclusions Circulating PACAP levels were associated with altered neuronal density of the EC but not hippocampus or amygdala. These findings strengthen evidence that PACAP may impact arousal- associated memory circuits.Competing Interest StatementWithin the past 3 years, WAC has served as a consultant for Psy Therapeutics and has sponsored research agreements with Cerevel and Delix. NPD has served on scientific advisory boards for BioVie Pharma, Circular Genomics and Sentio Solutions for unrelated work. KJR has performed scientific consultation for Acer, Bionomics, and Jazz Pharma; serves on Scientific Advisory Boards for Sage, Boehringer Ingelheim, Senseye, Brain and Behavior Research Foundation and the Brain Research Foundation, and he has received sponsored research support from Alto Neuroscience. SLR paid as secretary of Society of Biological Psychiatry, and for Board service to Mindpath Health/Community Psychiatry and National Association of Behavioral Healthcare; served as volunteer member of the Board for The National Network of Depression Centers; received royalties from Oxford University Press, American Psychiatric Publishing Inc, and Springer Publishing; received research funding from NIMH. EAO is employed by Crisis Text Line.Funding StatementThis work was supported by NIH awards P50MH115874 (to WAC and KJR, PDs; IMR, SLR, Project 4 PIs), R01MH120400 (IMR), R01MH97988 (SEH and VM), and NM119467 (CR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Committee of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors